Compounds > 1-(3-chlorophenyl)piperazine
Page last updated: 2024-10-21

1-(3-chlorophenyl)piperazine and Premenstrual Syndrome

1-(3-chlorophenyl)piperazine has been researched along with Premenstrual Syndrome in 2 studies

1-(3-chlorophenyl)piperazine: supposed metabolite of TRAZODONE; RN given refers to parent cpd; structure
1-(3-chlorophenyl)piperazine : A N-arylpiperazine that is piperazine carrying a 3-chlorophenyl substituent at position 1. It is a metabolite of the antidepressant drug trazodone.

Premenstrual Syndrome: A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Su, TP2
Schmidt, PJ2
Danaceau, M1
Murphy, DL2
Rubinow, DR2
Danaceau, MA1
Tobin, MB1
Rosenstein, DL1

Trials

2 trials available for 1-(3-chlorophenyl)piperazine and Premenstrual Syndrome

ArticleYear
Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls.
    The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:4

    Topics: Adult; Affect; Behavior; Female; Follicular Phase; Hormones; Humans; Luteal Phase; Menstrual Cycle;

1997
Fluoxetine in the treatment of premenstrual dysphoria.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1997, Volume: 16, Issue:5

    Topics: Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Female; Fluoxetine; Humans; Mi

1997